Goldman Sachs’s Cano Health, Inc. CANO Stock Holding History

Goldman Sachs’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,131	Closed	-$105K	–	5973
2023 Q3	$105K	Sell	4,131 -4,808	-54%	-$395K	﹤0.01%	5174
2023 Q2	$1.24M	Buy	8,939 +3,981	+80%	+$511K	﹤0.01%	4200
2023 Q1	$451K	Sell	4,958 -5,485	-53%	-$745K	﹤0.01%	4879
2022 Q4	$1.43M	Sell	10,443 -6,849	-40%	-$2.32M	﹤0.01%	4175
2022 Q3	$15M	Sell	17,292 -37,753	-69%	-$23.7M	﹤0.01%	2121
2022 Q2	$24.1M	Buy	55,045 +31,500	+134%	+$16.4M	0.01%	1748
2022 Q1	$15M	Buy	23,545 +12,816	+119%	+$8.08M	﹤0.01%	2299
2021 Q4	$9.56M	Buy	10,729 +7,593	+242%	+$7.98M	﹤0.01%	2814
2021 Q3	$3.98M	Buy	3,136 +2,332	+290%	+$2.83M	﹤0.01%	3554
2021 Q2	$973K	Buy	+804	New	+$1.08M	﹤0.01%	4783
2020 Q4	–	Sell	-2,483	Closed	-$2.58M	–	5779
2020 Q3	$2.58M	Buy	+2,483	New	+$2.6M	﹤0.01%	3384

Other funds holding CANO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs's CANO Position: Q4 2023 in Review

Goldman Sachs sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 4,131 shares — an estimated $105K sold.

Goldman Sachs first reported a position in CANO in Q3 2020 and held it in 11 quarters. The position peaked at $24.1M in Q2 2022. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

Goldman Sachs reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
Goldman Sachs sold 4,131 Cano Health, Inc. shares in Q4 2023, an estimated $105K.
Goldman Sachs first reported a position in Cano Health, Inc. in Q3 2020 and held it in 11 quarters.
Goldman Sachs's Cano Health, Inc. position peaked at $24.1M in Q2 2022.
50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.